Prolonged‐release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients

This study provides the first evidence that co-administration of prolonged-release oxycodone and existing gabapentin therapy has a clinically meaningful effect in painful diabetic neuropathy.